INFECTIOUS DISEASES / RESEARCH LETTER
 
TOPICS
REFERENCES (26)
1.
Nittas V, Gao M, West EA, et al. Long COVID through a public health lens: an umbrella review. Public Health Rev 2022; 43: 1604501.
 
2.
Venkatesan P. NICE guideline on long COVID. Lancet Respir Med 2021; 9: 129.
 
4.
Ballering AV, Van Zon SKR, Olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 2022; 400: 452-61.
 
5.
Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 2022; 28: 1461-7.
 
6.
Ayoubkhani D, Bosworth ML, King S, et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum Infect Dis 2022; 9: ofac464.
 
7.
Bull-Otterson L, Baca S, Saydah S, et al. Post-COVID conditions among adult COVID-19 survivors aged 18–64 and ≥ 65 years — United States, March 2020–November 2021. MMWR Morb Mortal Wkly Rep 2022; 71: 713-7.
 
8.
Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 2022; 101: 93-135.
 
9.
Castanares-Zapatero D, Chalon P, Kohn L, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 2022; 54: 1473-87.
 
10.
Babicki M, Lejawa M, Osadnik T, et al. LC risk score - development and evaluation of a scale for assessing the risk of developing long COVID. Arch Med Sci 2025; 21: 121-30.
 
11.
Lewek J, Jatczak-Pawlik I, Maciejewski M, Jankowski P, Banach M. COVID-19 and cardiovascular complications – the preliminary results of the LATE-COVID study. Arch Med Sci 2021; 17: 818-22.
 
12.
Jatczak-Pawlik I, Lewek J, Czkwianianc E, et al. Biochemical and cardiovascular predictors of PIMS-TS risk in children after COVID-19 recovery: preliminary results of the LATE-COVID-Kids Study. Arch Med Sci 2022; 18: 545-52.
 
13.
Gluckman TJ, Bhave NM, Allen LA, et al. 2022 ACC Expert Consensus Decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 Infection, and return to play. J Am Coll Cardiol 2022; 79: 1717-56.
 
14.
Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022; 28: 583-90.
 
15.
Terzic CM, Medina-Inojosa BJ. Cardiovascular complications of coronavirus disease-2019. Phys Med Rehabil Clin N Am 2023; 34: 551-61.
 
16.
Gonzalez-Gonzalez FJ, Ziccardi MR, McCauley MD. Virchow’s triad and the role of thrombosis in COVID-related stroke. Front Physiol 2021; 12: 769254.
 
17.
Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J 2022; 43: 1157-72.
 
18.
Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol 2022; 19: 332-41.
 
19.
Alkodaymi MS, Omrani OA, Fawzy NA, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect 2022; 28: 657-66.
 
20.
Chang WT, Toh HS, Liao CT, Yu WL. Cardiac involvement of COVID-19: a comprehensive review. Am J Med Sci 2021; 361: 14-22.
 
21.
Lavelle MP, Desai AD, Wan EY. Arrhythmias in the COVID-19 patient. Heart Rhythm O2 2022; 3: 8-14.
 
22.
Coromilas EJ, Kochav S, Goldenthal I, et al. Worldwide survey of COVID-19-associated arrhythmias. Circ Arrhythm Electrophysiol 2021; 14: e009458.
 
23.
la Roi-Teeuw HM, van Smeden M, Geersing GJ, et al. Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and validation study. Eur Heart J Open 2023; 3: eoad101.
 
24.
Tsampasian V, Elghazaly H, Chattopadhyay R, et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med 2023; 183: 566-80.
 
25.
Bhaskar S, Jovanovic S, Katyal A, Namboodiri NK, Chatzis D, Banach M. Is COVID-19 another case of the obesity paradox? Results from an international ecological study on behalf of the REPROGRAM Consortium Obesity study group. Arch Med Sci 2023; 19: 25-34.
 
26.
Fei J, Fu L, Li Y, et al. Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study. Arch Med Sci 2023; 19: 1303-13.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top